4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-068370
See Remarks sold 25,000 shares at $25.56 ($639,048)
- See Remarks acquired 25,000 shares (option exercise)
- See Remarks acquired 1,164 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2023-12-01 | Option exercise 10b5-1 | +10,009 | $2.61 | $26,123 | 83,300 | D |
| Maduck Sean See Remarks | 2023-12-01 | Option exercise 10b5-1 | +14,991 | $3.29 | $49,320 | 98,291 | D |
| Maduck Sean See Remarks | 2023-12-01 | Sale 10b5-1 | −25,000 | $25.56 | $639,048 | 73,291 | D |
| Maduck Sean See Remarks | 2023-12-01 | Grant or award 10b5-1 | +582 | $25.97 | $15,115 | 73,873 | D |
| Maduck Sean See Remarks | 2023-12-01 | Grant or award 10b5-1 | +582 | 74,455 | D | ||
| Derivatives | |||||||
| Maduck Sean See Remarks | 2023-12-01 | Option exercise · Stock option (right to buy) 10b5-1 | −10,009 | 10,000 | D | ||
| Maduck Sean See Remarks | 2023-12-01 | Option exercise · Stock option (right to buy) 10b5-1 | −14,991 | 16,986 | D | ||
| Open-market sales · 25,000 sh · avg $25.56 · $639,048 | |||||||
Loading xslF345X05/ownership.xml…